Most Recent

image: Opinion: Improving FDA Evaluations Without Jeopardizing Safety and Efficacy

Opinion: Improving FDA Evaluations Without Jeopardizing Safety and Efficacy

By | February 1, 2017

What can be done to lower development costs and drug prices?

4 Comments

New approaches to treating cancer have shown great promise, but they also come with serious risks that give us cause for concern.

1 Comment

image: Opinion: The Impact Factor, Re-envisioned

Opinion: The Impact Factor, Re-envisioned

By , , and | November 18, 2016

A combination of the traditional metric and the newer h5 index potentiates the scientific community toward more-balanced evaluation. 

2 Comments

image: Opinion: Repairing Peer Review

Opinion: Repairing Peer Review

By | November 18, 2016

Peer review is in crisis, but should be fixed, not abolished.

2 Comments

image: Opinion: Stop Submitting Papers

Opinion: Stop Submitting Papers

By | October 13, 2016

This is not sustainable.

1 Comment

image: Opinion: A Baseball Analogy

Opinion: A Baseball Analogy

By | July 26, 2016

Stiff competition under the current biomedical publishing model prevents important work from reaching a wider community in a timely manner. 

1 Comment

image: Opinion: Two Steps Toward Establishing Priority of Discovery

Opinion: Two Steps Toward Establishing Priority of Discovery

By | July 19, 2016

Establishing priority of a new finding is best achieved through a combination of a rapid, scientist-controlled disclosure followed by subsequent validation, through journal-based peer review and other mechanisms.

1 Comment

image: Opinion: The Zika Effect

Opinion: The Zika Effect

By | May 27, 2016

Three reasons why virologists are flocking to study this emerging virus

3 Comments

image: Opinion: Reimagining the Paper

Opinion: Reimagining the Paper

By | May 2, 2016

Breaking down lengthy, narrative-driven biomedical articles into brief reports on singular observations or experiments could increase reproducibility and accessibility in the literature.

3 Comments

image: Book Review: <em>Personal Trials</em>

Book Review: Personal Trials

By | March 22, 2016

At first blush, do-it-yourself clinical trials seem pointless and reckless. But a deeper truth pervades the research and the patients who drive it forward.

0 Comments

Popular Now

  1. Broad Wins CRISPR Patent Interference Case
    Daily News Broad Wins CRISPR Patent Interference Case

    The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.

  2. Cannibalism: Not That Weird
    Reading Frames Cannibalism: Not That Weird

    Eating members of your own species might turn the stomach of the average human, but some animal species make a habit of dining on their own.

  3. Henrietta Lacks’s Family Seeks Compensation
  4. Can Plants Learn to Associate Stimuli with Reward?
Business Birmingham